Quantcast
Last updated on April 18, 2014 at 6:50 EDT

Latest Sanovas Inc. Stories

2014-04-14 12:34:00

SAUSALITO, Calif., April 14, 2014 /PRNewswire/ -- Sanovas Inc., a Life Sciences Accelerator developing and commercializing next-generation micro-invasive diagnostics, devices and drug delivery technologies, announced today that it has appointed Jeff Heer to serve as Chief Operating Officer. Previously, Jeff was Vice President of Manufacturing and Customer Support at Picarro Inc., a leading provider of solutions to measure rare gases for applications across the Energy/Utility and...

2014-03-13 08:27:54

Innovation intended to improve cytology yields by up to 800 percent SAUSALITO, Calif., March 13, 2014 /PRNewswire/ -- Sanovas, Inc., (www.sanovas.com) a life science technology company focused on developing and commercializing next generation micro-invasive diagnostics, devices and drug delivery technologies announced today that the United States Patent and Trademark Office issued patent # 8,668,654 for the company's Cytological Brushing System. The Cytological Brushing System is a...

2013-12-03 08:31:23

Swiss Army Knife of Interventional Catheters Heralds New Era in Drug Delivery SAUSALITO, Calif., Dec. 3, 2013 /PRNewswire/ -- Sanovas, Inc., (www.sanovas.com) a life science technology company focused on developing and commercializing next generation micro-invasive diagnostics, devices and drug delivery technologies announced today that the United States Patent and Trademark Office issued patent # 8,597,239 for the company's Abrading Balloon Catheter for Extravasated Drug Delivery....

2013-10-29 08:31:06

New Scientific Method Delivers Diagnostic & Therapeutic Agents Directly to Target Tissues SAUSALITO, Calif., Oct. 29, 2013 /PRNewswire/ -- Sanovas Inc., (www.sanovas.com) a life science technology company focused on developing and commercializing next generation micro-invasive diagnostics, devices and drug delivery technologies, announced today that the United States Patent and Trademark Office issued patent # 8,540,667 for the company's Multi-Balloon Catheter for Extravasated Drug...

2013-06-20 08:25:52

Collaboration intended to advance techniques in modification of bronchial smooth muscle SAUSALITO, Calif., June 20, 2013 /PRNewswire/ -- Sanovas, Inc., a leading developer of micro invasive surgical solutions for the Interventional Pulmonary Science, announced today that it has entered into a patent license and joint development agreement with Mayo Clinic to commercialize a significant innovation in the emerging science of bronchial smooth muscle modification. The collaboration is...

2013-04-22 08:28:14

OEM Platform Promises To Revolutionize Endoscopic Imaging Market SAUSALITO, Calif., April 22, 2013 /PRNewswire/ -- Sanovas Inc., a life science technology company developing and commercializing the next-generation of micro-invasive diagnostics, devices and drug delivery technologies, announced today the launch of MicroCam(TM), its OEM "Plug & Play" micro imaging platform for endoscopic device applications. The technology features proprietary software, electronics, sensors and...

2013-01-17 08:25:52

SAUSALITO, Calif., Jan. 17, 2013 /PRNewswire/ -- Sanovas Inc., a life science technology company developing and commercializing the next-generation of micro-invasive diagnostics, devices and drug delivery technologies, announced today that it has filed with the U.S. Food and Drug Administration for clearance of the company's Vas Zeppelin(TM) Smart Catheter(TM) for the treatment of chronic pulmonary diseases and lung cancer. The technology would be among the smallest interventional...

2012-12-03 08:28:04

SAUSALITO, Calif., Dec. 3, 2012 /PRNewswire/ -- Sanovas, Inc., a life science technology company focused on developing and commercializing the next-generation of micro-invasive diagnostics, devices and drug delivery technologies, and the World Association of Bronchology & Interventional Pulmonology (WABIP) today announced that they have launched a joint research project entitled "The Breathing Innovation Survey - We Are Listening." The global initiative, being conducted via multiple...

2012-11-19 08:27:54

SAUSALITO, Calif., Nov. 19, 2012 /PRNewswire/ -- Sanovas, Inc., a life science technology company focused on developing and commercializing the next-generation of micro-invasive diagnostics, devices and drug delivery technologies, announced today that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for the company's nested balloon catheter for localized drug delivery, a component of Sanovas' Vas Zeppelin(TM) Smart Catheter technology portfolio. The...

2012-09-11 02:28:45

SAUSALITO, Calif., Sept. 11, 2012 /PRNewswire/ -- Sanovas Inc., a life science technology company focused on developing and commercializing the next-generation of micro-invasive diagnostics, devices and drug delivery technologies, announced today that it has hired three industry veterans to serve on its executive team. Mike Humason joins Sanovas as vice president of clinical affairs and physician education; Carlos Gonzalez joins as vice president of regulatory affairs and quality assurance,...